Pathology of the bone marrow and spleen in a case of myelodysplastic/myeloproliferative neoplasm associated with t(8;9)(p22;p24) involving PCM1 and JAK2 genes

被引：10
作者：
Dargent, Jean-Louis [1 ]
Mathieux, Valerie [2 ]
Vidrequin, Sebastien [1 ]
Deghorain, Xavier [1 ]
Vannuffel, Pascal [1 ]
Rack, Katrina [1 ]
机构：
[1] Inst Pathol & Genet, B-6041 Gosselies, Belgium
[2] Clin St Elizabeth, Serv Hematol, Namur, Belgium
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2011年 / 86卷 / 01期
关键词：
PCM1-JAK2; FUSION; TRANSLOCATION; LEUKEMIA; DISORDERS;
D O I：
10.1111/j.1600-0609.2010.01525.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：87 / 90
页数：4
相关论文
共 12 条
  • [1] A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma
    Adélaïde, J
    Pérot, C
    Gelsi-Boyer, V
    Pautas, C
    Murati, A
    Copie-Bergman, C
    Imbert, M
    Chaffanet, M
    Birnbaum, D
    Mozziconacci, MJ
    [J]. LEUKEMIA, 2006, 20 (03) : 536 - 537
  • [2] [Anonymous], 2008, WHO CLASSIFICATION T
  • [3] The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene
    Bousquet, M
    Quelen, C
    De Mas, V
    Duchayne, E
    Roquefeuil, B
    Delsol, G
    Laurent, G
    Dastugue, N
    Brousset, P
    [J]. ONCOGENE, 2005, 24 (48) : 7248 - 7252
  • [4] Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case
    Heiss, S
    Erdel, M
    Gunsilius, E
    Nachbaur, D
    Tzankov, A
    [J]. HUMAN PATHOLOGY, 2005, 36 (10) : 1148 - 1151
  • [5] Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia
    Huang, Kuan-Po
    Chase, Andrew J.
    Cross, Nicholas C. P.
    Reiter, Andrea
    Li, Tzu-Ying
    Wang, Tso-Fu
    Chu, Sung-Chao
    Lu, Xuan-Yin
    Li, Chi-Cheng
    Kao, Ruey-Ho
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 197 - 201
  • [6] Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibrosis in vivo
    Kennedy, J. A.
    Barabe, F.
    Patterson, B. J.
    Bayani, J.
    Squire, J. A.
    Barber, D. L.
    Dick, J. E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (45) : 16930 - 16935
  • [7] PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
    Murati, A
    Gelsi-Boyer, V
    Adélaïde, J
    Perot, C
    Talmant, P
    Giraudier, S
    Lodé, L
    Letessier, A
    Delaval, B
    Brunel, V
    Imbert, M
    Garand, R
    Xerri, L
    Birnbaum, D
    Mozziconacci, M
    Chaffanet, M
    [J]. LEUKEMIA, 2005, 19 (09) : 1692 - 1696
  • [8] Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms
    Naifeld, Vesna
    Cozza, Amanda
    Berkofsy-Fessler, Windy
    Prehal, Josef
    Scalise, Angela
    [J]. EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) : 1668 - 1676
  • [9] Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates
    Patnaik, Mrinal M.
    Knudson, Ryan A.
    Gangat, Naseema
    Hanson, Curtis A.
    Pardanani, Animesh
    Tefferi, Ayalew
    Ketterling, Rhett P.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (06) : 518 - 524
  • [10] The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2
    Reiter, A
    Walz, C
    Watmore, A
    Schoch, C
    Blau, I
    Schlegelberger, B
    Berger, U
    Telford, N
    Aruliah, S
    Yin, JA
    Vanstraelen, D
    Barker, HF
    Taylor, PC
    O'Driscoll, A
    Benedetti, F
    Rudolph, C
    Kolb, HJ
    Hochhaus, A
    Hehlmann, R
    Chase, A
    Cross, NCP
    [J]. CANCER RESEARCH, 2005, 65 (07) : 2662 - 2667
12